Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Lifestar Pharma LLC, priced at $0.1067 per EA under NDC 70756080790. Its NADAC has been published 424 times since May 16, 2018.
Strength
30 mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756080790
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205868On Market Since
6/4/2018
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 424 times since May 16, 2018, and over the history we have for it it has declined 48.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1067 per EA |
|---|---|
| All-time high | $0.2139 (Aug 15, 2018) |
| All-time low | $0.0754 (Nov 20, 2024) |
| 52-week high | $0.1104 |
| 52-week low | $0.1049 |
| Median price | $0.1225 |
| Average price | $0.1367 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 424 |
| Tracking since | May 16, 2018 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Lifestar Pharma LLC, is $0.1067 per EA (NDC 70756080790), effective Jun 24, 2026.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 48.4%. It has been tracked across 424 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since May 16, 2018, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.0754 (Nov 20, 2024) to a high of $0.2139 (Aug 15, 2018), with a median of $0.1225 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
9 NADAC-published products share the same active ingredient, strength, and dosage form as LANSOPRAZOLE DR 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 70756080790) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification